Tumor microenvironment promotes prostate cancer cell dissemination via the Akt/mTOR pathway

Junlin Shi,Lihui Wang,Chunlin Zou,Yudui Xia,Siyuan Qin,Evan Keller,Atsushi Mizokami,Jian Zhang,Yi Lu

DOI: https://doi.org/10.18632/oncotarget.24104

2018-01-09

Oncotarget

Abstract:Metastasis causes high mortality in various malignancies, including prostate cancer (PCa). Accumulating data has suggested that cancer cells spread from the primary tumor to distant sites at early stage, which is characterized by disseminated tumor cells (DTCs). However, lack of direct evidence of partial localized PCa cells occurring epithelial-to-mesenchymal transition (EMT) and disseminating to distant sites (e.g bone marrow). In this study, we used luciferase labeled PCa cells to establish an EMT mouse model and to detect whether DTCs spread into the bone marrow. We observed tumor cells existing in mouse bone marrow when tumor grew subcutaneously at palpable stage. Studies also showed that <i>ex vivo</i> tumor cells exhibited increased proliferative, migratory, invasive and angiogenesis abilities. When compared <i>ex vivo</i> tumor cells with parental cells, hallmarks of EMT including E-cadherin, Vimentin, Snail, and ZO-1 were altered significantly. Specifically, the <i>ex vivo</i> tumor cells showed more mesenchymal properties. Angiogenesis markers, including VEGFR2, VEGFR3, MCP-3, I-TAC, I309, uPAR and GROα, were also increased in the <i>ex vivo</i> tumor cells. Intriguingly, MCP-1 expression was dramatically increased in those cells. Mechanistic analyses indicated that AP1 mediates PCa EMT and the appearance of DTCs via the Akt/mTOR pathway. This study may provide potential therapeutic targets and diagnostic biomarkers of PCa progression and metastasis.